Glioblastoma: Molecular Pathways, Stem Cells and Therapeutic Targets
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glioblastoma: Molecular Pathways, Stem Cells and Therapeutic Targets
Authors
Keywords
-
Journal
Cancers
Volume 7, Issue 2, Pages 538-555
Publisher
MDPI AG
Online
2015-03-25
DOI
10.3390/cancers7020538
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway
- (2016) Lioubov G. Korotchkina et al. Aging-US
- Epigenetic Regulation of miRNA-211 by MMP-9 Governs Glioma Cell Apoptosis, Chemosensitivity and Radiosensitivity
- (2015) Swapna Asuthkar et al. Oncotarget
- MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1
- (2015) Ariel Bier et al. Oncotarget
- International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading
- (2014) David N. Louis et al. BRAIN PATHOLOGY
- Osteopontin-CD44 Signaling in the Glioma Perivascular Niche Enhances Cancer Stem Cell Phenotypes and Promotes Aggressive Tumor Growth
- (2014) Alexander Pietras et al. Cell Stem Cell
- A lentivirus-mediated miR-23b sponge diminishes the malignant phenotype of glioma cells in vitro and in vivo
- (2014) LUYUE CHEN et al. ONCOLOGY REPORTS
- Trial Watch
- (2014) Fernando Aranda et al. OncoImmunology
- C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells
- (2013) Pin Guo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MiR-26a enhances the radiosensitivity of glioblastoma multiforme cells through targeting of ataxia–telangiectasia mutated
- (2013) Pin Guo et al. EXPERIMENTAL CELL RESEARCH
- Oncogenic effects of miR-10b in glioblastoma stem cells
- (2013) Fadila Guessous et al. JOURNAL OF NEURO-ONCOLOGY
- Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial
- (2013) Manfred Westphal et al. LANCET ONCOLOGY
- MicroRNA-153 is tumor suppressive in glioblastoma stem cells
- (2013) Shiguang Zhao et al. MOLECULAR BIOLOGY REPORTS
- Differential Expression of MicroRNAs in Patients with Glioblastoma after Concomitant Chemoradiotherapy
- (2013) Edmond Changkyun Park et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid
- (2013) MARISSA D. FRIEDMAN et al. ONCOLOGY REPORTS
- Prominin 1/CD133 Endothelium Sustains Growth of Proneural Glioma
- (2013) Bi-Sen Ding et al. PLoS One
- Involvement of miRNAs in the Differentiation of Human Glioblastoma Multiforme Stem-Like Cells
- (2013) Beatriz Aldaz et al. PLoS One
- microRNA-100 Targets SMRT/NCOR2, Reduces Proliferation, and Improves Survival in Glioblastoma Animal Models
- (2013) Bahauddeen M. Alrfaei et al. PLoS One
- Strategies in Gene Therapy for Glioblastoma
- (2013) Aneta Kwiatkowska et al. Cancers
- Glioblastoma cancer stem cells: Role of the microenvironment and therapeutic targeting
- (2012) Luca Persano et al. BIOCHEMICAL PHARMACOLOGY
- Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
- (2012) Hilko Ardon et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunohistochemical analysis-based proteomic subclassification of newly diagnosed glioblastomas
- (2012) Kazuya Motomura et al. CANCER SCIENCE
- The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer
- (2012) T. Shimizu et al. CLINICAL CANCER RESEARCH
- The Definition of Primary and Secondary Glioblastoma
- (2012) H. Ohgaki et al. CLINICAL CANCER RESEARCH
- PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma
- (2012) Pedro M. Costa et al. HUMAN MOLECULAR GENETICS
- MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma
- (2012) Pedro M. Costa et al. HUMAN MOLECULAR GENETICS
- Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma
- (2012) Qiong Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme
- (2012) D Yin et al. ONCOGENE
- MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1
- (2012) YANWEI LIU et al. ONCOLOGY REPORTS
- Monitoring of Regulatory T Cell Frequencies and Expression of CTLA-4 on T Cells, before and after DC Vaccination, Can Predict Survival in GBM Patients
- (2012) Brendan Fong et al. PLoS One
- Comparison of L1 expression and secretion in glioblastoma and neuroblastoma cells
- (2012) WEIJIANG ZHAO Oncology Letters
- Trial watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Current Strategies for Identification of Glioma Stem Cells: Adequate or Unsatisfactory?
- (2012) Paola Brescia et al. Journal of Oncology
- Improving prognosis of glioblastoma in the 21st century: Who has benefited most?
- (2011) Yaacov Richard Lawrence et al. CANCER
- Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence
- (2011) Zoya N. Demidenko et al. CELL CYCLE
- A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma
- (2011) Chen-Nen Chang et al. JOURNAL OF CLINICAL NEUROSCIENCE
- MEK-ERK Signaling Dictates DNA-Repair Gene MGMT Expression and Temozolomide Resistance of Stem-Like Glioblastoma Cells via the MDM2-p53 Axis
- (2011) Atsushi Sato et al. STEM CELLS
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
- (2010) Houtan Noushmehr et al. CANCER CELL
- TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human Glioblastoma
- (2010) Judit Anido et al. CANCER CELL
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- miR-195, miR-455-3p and miR-10a∗ are implicated in acquired temozolomide resistance in glioblastoma multiforme cells
- (2010) Kenta Ujifuku et al. CANCER LETTERS
- Glioma Cell Populations Grouped by Different Cell Type Markers Drive Brain Tumor Growth
- (2010) Lars Prestegarden et al. CANCER RESEARCH
- Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy
- (2010) Robert M. Prins et al. CLINICAL CANCER RESEARCH
- Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-β
- (2010) Hanning You et al. HEPATOLOGY
- Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status
- (2010) Xuan Zhou et al. LABORATORY INVESTIGATION
- EGFRvIII-Targeted Vaccination Therapy of Malignant Glioma
- (2009) Bryan D. Choi et al. BRAIN PATHOLOGY
- TGF-β Increases Glioma-Initiating Cell Self-Renewal through the Induction of LIF in Human Glioblastoma
- (2009) Silvia Peñuelas et al. CANCER CELL
- mTOR Signal and Hypoxia-Inducible Factor-1 Regulate CD133 Expression in Cancer Cells
- (2009) K. Matsumoto et al. CANCER RESEARCH
- mTOR Mediates Wnt-Induced Epidermal Stem Cell Exhaustion and Aging
- (2009) Rogerio M. Castilho et al. Cell Stem Cell
- Physiologic Oxygen Concentration Enhances the Stem-Like Properties of CD133+ Human Glioblastoma Cells In vitro
- (2009) A. M. McCord et al. MOLECULAR CANCER RESEARCH
- An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
- (2009) J. H. Sampson et al. MOLECULAR CANCER THERAPEUTICS
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution
- (2009) S G M Piccirillo et al. ONCOGENE
- Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
- (2009) A Soeda et al. ONCOGENE
- Proliferation of Human Glioblastoma Stem Cells Occurs Independently of Exogenous Mitogens
- (2009) John J. P. Kelly et al. STEM CELLS
- Postoperative Adjuvant Dendritic Cell-Based Immunotherapy in Patients with Relapsed Glioblastoma Multiforme
- (2008) S. De Vleeschouwer et al. CLINICAL CANCER RESEARCH
- Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients
- (2008) F. Zeppernick et al. CLINICAL CANCER RESEARCH
- MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators
- (2008) G. Gabriely et al. MOLECULAR AND CELLULAR BIOLOGY
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
- CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells
- (2007) Jian Wang et al. INTERNATIONAL JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started